Table 3.
Trial | Clinical study report | Informed consent form | Register | Publication |
V501-012 | 225 mcg of aluminium as AAHS in normal saline | Inactive solution (containing aluminium 225 mcg/dose) | Control intervention not listed | Aluminium-containing placebo |
V501-013 | 225 mcg of aluminium as AAHS in normal saline | Inactive solution (containing aluminium 225 mcg/dose) | No ingredients listed; only states ‘placebo’ | Aluminium-containing placebo |
V501-015 | 225 mcg of aluminium as AAHS in normal saline | Inactive solution (containing aluminium 225 mcg/dose) | No ingredients listed; only states ‘placebo’ | Aluminium-containing placebo |
V501-019 | Merck standard aluminium diluent (225 mcg alum) in normal saline | No ingredients listed. Only states: ‘The HPV vaccine placebo contains no active vaccine’ | No ingredients listed; only states ‘placebo’ | Aluminium-containing placebo |
V501-020 | 225 mcg of aluminium as AAHS in normal saline | No ingredients listed. Only states: ‘placebo, an injection that looks the same as the vaccine but has no active ingredient’ | No ingredients listed; only states ‘placebo’ | AAHS-containing placebo |
Normal saline = USP (NaCl 0.9%).
AAHS, amorphous aluminum hydroxyphosphate sulfate.